美国甲状腺协会超声风险分层系统无法分类的甲状腺结节的恶性风险:系统评价与Meta分析
该系统评价与Meta分析检索2016至2022年使用美国甲状腺协会(ATA)超声风险分层系统(USRSS)分类并报告无法分类(NC-ATA)结节结局的原始研究。16项研究共21,271个结节纳入,NC-ATA结节合并患病率为7.8%(CI 5.1-11.1),合并恶性风险(RoM)为20.3%(CI 13.0-28.7),与ATA USRSS中等怀疑类别相当,但研究间异质性显著(I²=92.8%,p<0.001)。
要点
- NC-ATA结节合并患病率为7.8%(CI 5.1-11.1),合并恶性风险为20.3%(CI 13.0-28.7)。
- NC-ATA结节恶性风险与ATA USRSS中等怀疑类别相当。
- 研究间异质性显著(I²=92.8%,p<0.001),限制了结果解读。
核心结论
- 这是首个全面评估NC-ATA结节恶性风险的Meta分析,其恶性风险与当前ATA USRSS中等怀疑类别相当。
- 研究间存在显著异质性,限制了这些结果的解读。
- 未来ATA USRSS修订若纳入NC-ATA结节分类,该Meta分析数据可能有助于指导适当的恶性风险分层。
研究设计与样本
- 系统评价与Meta分析,检索PubMed/MEDLINE和EMBASE,纳入2016至2022年使用ATA USRSS分类甲状腺结节并报告NC-ATA结节结局的原始研究。
- 共筛选6377项研究,135项进行全文审查,最终纳入16项研究、报告21,271个结节。
- 研究方案于2020年7月14日在PROSPERO注册(CRD42020182498)。
主要发现
- NC-ATA结节合并患病率为7.8%(1872个结节;CI 5.1-11.1)。
- NC-ATA结节合并恶性风险估计为20.3%(CI 13.0-28.7),研究间异质性显著(I²=92.8%,p<0.001)。
- 单中心研究NC-ATA结节恶性风险为24.8%,多中心研究为12.3%(p=0.031)。
- 回顾性研究NC-ATA结节恶性风险为25.1%,前瞻性研究为8.5%(p=0.003)。
- 纳入<1 cm结节或地理区域对恶性风险无显著差异;Meta回归显示研究设计和采用手术组织学作为诊断标准对报告的恶性风险估计差异有显著贡献。
关键数值与推荐
- NC-ATA结节合并患病率为7.8%(CI 5.1-11.1)。
- NC-ATA结节合并恶性风险为20.3%(CI 13.0-28.7),与ATA USRSS中等怀疑类别相当。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究间异质性显著(I²=92.8%,p<0.001),限制了这些结果的解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Sonographic evaluation is fundamental to thyroid nodule assessment. The American Thyroid Association (ATA) ultrasound risk stratification system (USRSS) is widely used, but the appearance of some nodules has been considered nonclassifiable (NC-ATA). The risk of malignancy (RoM) of NC-ATA nodules varies widely between studies, leading to uncertainty in clinical management. The aim of this study was to comprehensively evaluate the prevalence and malignancy risk of NC-ATA nodules. Methods: A systematic review was performed searching PubMed/MEDLINE and EMBASE to identify original studies of thyroid nodules classified using the ATA USRSS from 2016 to 2022 and reporting the outcome of NC-ATA nodules. Meta-analysis was conducted to obtain pooled RoM estimates and meta-regression sensitivity analyses were used to explore sources of between-study heterogeneity. Results: Of 6377 screened studies, 135 underwent full-text review, and 16 studies reporting 21,271 nodules were included. Within these, the pooled prevalence of NC-ATA nodules was 7.8% (1872 nodules; [confidence interval; CI 5.1-11.1]). The pooled RoM estimate for NC-ATA nodules was 20.3% [CI 13.0-28.7] and there was significant heterogeneity between studies (I2 = 92.8%, p < 0.001). NC-ATA nodule RoM estimates were significantly different by study type: single-center versus multicenter studies (24.8% vs. 12.3%, respectively, p = 0.031) and study design: retrospective versus prospective studies (25.1% vs. 8.5%, respectively, p = 0.003). No significant difference was observed in RoM based on inclusion of <1 cm nodules or geographic region. Meta-regression analysis showed study design and use of surgical histology for diagnostic criteria contributed significantly to differences in the reported RoM estimates. Conclusion: In this first meta-analysis comprehensively assessing the RoM of NC-ATA nodules, the malignancy risk was found to be comparable with the current ATA USRSS intermediate suspicion category. Significant heterogeneity was observed between studies and limits the interpretation of these results. In future iterations of the ATA USRSS that seek into incorporate categorization of NC-ATA nodules, these meta-analysis data may help to inform proper malignancy risk stratification. The study protocol was registered on PROSPERO, the international prospective register of systematic reviews (CRD42020182498), on July 14, 2020.
引用
- Kwon D, Kulich M, Mack WJ, et al. Malignancy Risk of Thyroid Nodules That Are Not Classifiable by the American Thyroid Association Ultrasound Risk Stratification System: A Systematic Review and Meta-Analysis. Thyroid. 2023. PMID: 36855336. doi:10.1089/thy.2022.0672
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。